Brief: Guardion Health Receives Letter From Nasdaq Saying It Has Not Regained Compliance With Price Requirement For Continued Listing
Dec 2 (Reuters) - Guardion Health Sciences Inc GHSI.O :
* GUARDION HEALTH SCIENCES - ON DEC 1, GOT LETTER FROM
NASDAQ
SAYING CO HAS NOT REGAINED COMPLIANCE WITH PRICE REQUIREMENT FOR
CONTINUED LISTING
Source: [ID:https://bit.ly/3g1g7Kd]
Further company coverage: GHSI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Guardion Health Sciences
See all newsBrief: Guardion Health Sciences Announces Termination Of CEO, Effective October 17
Brief: Guardion Health Sciences Announces Completion Of Sale Of Its Viactiv® Brand And Business To Doctor’S Best Inc. And Stockholder Approval Of Plan Of Liquidation And Dissolution
Brief: Guardion Health Sciences Announces Its Largest Stockholder Has Voted In Favor Of Proposals To Sell The Viactiv Business
Guardion Health Sciences Inc reports results for the quarter ended in March - Earnings Summary
Guardion Health Sciences Inc expected to post a loss of 88 cents a share - Earnings Preview